ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Roth Capital Raises Price on ICU Medical (ICUI) to $124 Following 2Q EPS Beat and Raise
August 11, 2015 8:17 AM EDTRoth Capital reiterated a Buy rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $124.00 (from $102.00), following the company's 2Q earnings release. 2Q revenues of $83.8 million beat Street's $78.89 million estimate. Adjusted EPS of $0.97 beat Street's $0.69. ICUI raised its annual outlook, which... More
